Case Reports
doi: 10.1007/BF00428906.
Clinical studies with dopamine-receptor stimulants
- PMID: 1208762
- DOI: 10.1007/BF00428906
Item in Clipboard
Case Reports
Clinical studies with dopamine-receptor stimulants
Psychopharmacologia.
.
Abstract
Oral administration of ET-495 was found to cause worsening of psychiatric status in 4 out of 7 schizophrenic patients, and to induce a paranoid state and a syndrome of auditory hallucinosis in 2 non-schizophrenics. These observations were compatible with the hypothesized role of dopamine in schizophrenia. However, these psychotogenic effects were far less dramatic than those noted in other studies with amphetamine, methylphenidate or L-Dopa. Possible explanations for this differing psychotogenic potency of receptor stimulators versus presynaptic agonists are presented. Intravenous ET-495 and apomorphine did not show psychotogenic effects.
Similar articles
-
The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.Arch Int Pharmacodyn Ther. 1985 May;275(1):22-32. Arch Int Pharmacodyn Ther. 1985. PMID: 4026462
-
The influence of piribedil (ET495) on components of locomotor activity.Eur J Pharmacol. 1975 Aug;33(1):211-5. doi: 10.1016/0014-2999(75)90160-0. Eur J Pharmacol. 1975. PMID: 1175688
-
Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.Br J Pharmacol. 1975 Mar;53(3):419-21. doi: 10.1111/j.1476-5381.1975.tb07378.x. Br J Pharmacol. 1975. PMID: 1173346 Free PMC article.
-
Biochemistry and the schizophrenia. Old concepts and new hypothesis.J Nerv Ment Dis. 1981 Feb;169(2):90-9. J Nerv Ment Dis. 1981. PMID: 7009786 Review.
-
[Cerebral dopaminergic mechanisms. Present status of the problem].Ann Med Psychol (Paris). 1979 Nov;137(9):925-9. Ann Med Psychol (Paris). 1979. PMID: 232829 Review. French. No abstract available.
Cited by
-
Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.Neurotox Res. 2004;6(1):63-71. doi: 10.1007/BF03033298. Neurotox Res. 2004. PMID: 15184107 Review.
-
New detection of brain dopamine receptors with (3H)dihydroergocryptine.Proc Natl Acad Sci U S A. 1977 Sep;74(9):3750-3. doi: 10.1073/pnas.74.9.3750. Proc Natl Acad Sci U S A. 1977. PMID: 410026 Free PMC article.
-
Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.J Neurosci. 2010 Oct 6;30(40):13513-24. doi: 10.1523/JNEUROSCI.1665-10.2010. J Neurosci. 2010. PMID: 20926677 Free PMC article.
-
The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness.Psychopharmacology (Berl). 1987;92(4):405-15. doi: 10.1007/BF00176470. Psychopharmacology (Berl). 1987. PMID: 2888150 Review.
-
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?J Psychiatry Neurosci. 2001 May;26(3):203-20. J Psychiatry Neurosci. 2001. PMID: 11394190 Free PMC article. Review.